Prostate Cancer Stem Cells: A Brief Review

作者: Xin Chen , Dean G. Tang

DOI: 10.1007/978-1-4614-6498-3_3

关键词:

摘要: Human cancers have been shown to harbor stem cell-like cells called cancer (CSCs). These are thought be endowed with indefinite self-renewal ability and believed involved in tumor initiation, promotion, progression, metastasis, therapy resistance. Prostate (PCa) also contain CSCs. Here we briefly review the literature reports of CSCs various systems. We then summarize studies prostate (PCSCs) human mouse models discuss their respective limitations. further current controversies respect identifying cell origin for PCa. Elucidating unique characteristics PCSCs will enhance our understanding mechanisms underlying emergence castration-resistant disease may provide new opportunities developing therapeutics that target recurrent

参考文章(80)
Zeng-Jie Yang, Tammy Ellis, Shirley L Markant, Tracy-Ann Read, Jessica D Kessler, Melissa Bourboulas, Ulrich Schüller, Robert Machold, Gord Fishell, David H Rowitch, Brandon J Wainwright, Robert J Wechsler-Reya, None, Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells. Cancer Cell. ,vol. 14, pp. 135- 145 ,(2008) , 10.1016/J.CCR.2008.07.003
Renea A. Taylor, Roxanne Toivanen, Mark Frydenberg, John Pedersen, Laurence Harewood, Australian Prostate Cancer Bioresou, Anne T. Collins, Norman J. Maitland, Gail P. Risbridger, Human epithelial basal cells are cells of origin of prostate cancer, independent of CD133 status. Stem Cells. ,vol. 30, pp. 1087- 1096 ,(2012) , 10.1002/STEM.1094
Ting Li, Yun Su, Yuping Mei, Qixin Leng, Bingjie Leng, Zhenqiu Liu, Sanford A Stass, Feng Jiang, ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome. Laboratory Investigation. ,vol. 90, pp. 234- 244 ,(2010) , 10.1038/LABINVEST.2009.127
Hong Yan, Xin Chen, Qiuping Zhang, Jichao Qin, Hangwen Li, Can Liu, Tammy Calhoun-Davis, Luis Della Coletta, Jim Klostergaard, Izabela Fokt, Stanislaw Skora, Waldemar Priebe, Yongyi Bi, Dean G. Tang, Drug-Tolerant Cancer Cells Show Reduced Tumor-Initiating Capacity: Depletion of CD44+ Cells and Evidence for Epigenetic Mechanisms PLoS ONE. ,vol. 6, pp. e24397- ,(2011) , 10.1371/JOURNAL.PONE.0024397
Ines A. Silva, Shoumei Bai, Karen McLean, Kun Yang, Kent Griffith, Dafydd Thomas, Christophe Ginestier, Carolyn Johnston, Angela Kueck, R. Kevin Reynolds, Max S. Wicha, Ronald J. Buckanovich, Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival. Cancer Research. ,vol. 71, pp. 3991- 4001 ,(2011) , 10.1158/0008-5472.CAN-10-3175
Stephen J. Curtis, Kerstin W. Sinkevicius, Danan Li, Allison N. Lau, Rebecca R. Roach, Raffaella Zamponi, Amber E. Woolfenden, David G. Kirsch, Kwok-Kin Wong, Carla F. Kim, Primary Tumor Genotype Is an Important Determinant in Identification of Lung Cancer Propagating Cells Cell Stem Cell. ,vol. 7, pp. 127- 133 ,(2010) , 10.1016/J.STEM.2010.05.021
Chenwei Li, David G. Heidt, Piero Dalerba, Charles F. Burant, Lanjing Zhang, Volkan Adsay, Max Wicha, Michael F. Clarke, Diane M. Simeone, Identification of Pancreatic Cancer Stem Cells Cancer Research. ,vol. 67, pp. 1030- 1037 ,(2007) , 10.1158/0008-5472.CAN-06-2030
Anne-Marie Bleau, Dolores Hambardzumyan, Tatsuya Ozawa, Elena I. Fomchenko, Jason T. Huse, Cameron W. Brennan, Eric C. Holland, PTEN/PI3K/Akt Pathway Regulates the Side Population Phenotype and ABCG2 Activity in Glioma Tumor Stem-like Cells Cell Stem Cell. ,vol. 4, pp. 226- 235 ,(2009) , 10.1016/J.STEM.2009.01.007